Review of Multimodality Management of Anaplastic Thyroid Cancer

This study has been completed.
Sponsor:
Information provided by:
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT00280852
First received: January 20, 2006
Last updated: November 18, 2011
Last verified: July 2011
  Purpose

To describe the outcome of patients with anaplastic thyroid cancer treated with hyperfractionated radiotherapy and concomitant chemotherapy


Condition
Anaplastic Thyroid Cancer

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: A Retrospective Review of Multimodality Management of Anaplastic Thyroid Cancer

Resource links provided by NLM:


Further study details as provided by AHS Cancer Control Alberta:

Enrollment: 5
Study Start Date: January 2006
Study Completion Date: June 2006
Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

anaplastic thyroid cancer

Criteria

Inclusion Criteria:

  • anaplastic thyroid cancer treated with multimodality treatment

Exclusion Criteria:

  • differentiated thyroid cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00280852

Locations
Canada, Alberta
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2
Sponsors and Collaborators
AHS Cancer Control Alberta
Investigators
Principal Investigator: Harold Lau, MD Alberta Cancerboard
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00280852     History of Changes
Other Study ID Numbers: 18940
Study First Received: January 20, 2006
Last Updated: November 18, 2011
Health Authority: Canada: Health Canada

Keywords provided by AHS Cancer Control Alberta:
anaplastic thyroid cancer
chemotherapy
radiotherapy

Additional relevant MeSH terms:
Thyroid Neoplasms
Thyroid Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Head and Neck Neoplasms
Endocrine System Diseases

ClinicalTrials.gov processed this record on August 27, 2014